Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
30 Apr - 02 Jun 2014
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2014
Report date:
2014

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Version / remarks:
adopted 22 July 2010
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
Hess. Ministerium für Umwelt, Energie, Landwirtschaft und Verbraucherschutz, Wiesbaden, Germany
Type of study:
mouse local lymph node assay (LLNA)

Test material

Constituent 1
Chemical structure
Reference substance name:
(1S,5R)-6,8-dioxabicyclo[3.2.1]octan-4-one
EC Number:
807-130-4
Cas Number:
53716-82-8
Molecular formula:
C6H8O3
IUPAC Name:
(1S,5R)-6,8-dioxabicyclo[3.2.1]octan-4-one
Details on test material:
- Name of test material (as cited in study report): Cyrene™- Analytical purity: 99%- Expiration date of the lot/batch: 30 Sep 2015- CAS RN: 53716-82-8

In vivo test system

Test animals

Species:
mouse
Strain:
other: CBA/CaOlaHsd
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Harlan Laboratories B. B., Horst, Netherlands
- Age at study initiation: 1st pre-test: 8 - 9 weeks; 2nd pre-test: 10 - 11 weeks; main study: 10 - 11 weeks
- Weight at study initiation: 1st pre-test: 19.8 - 21.3 g; 2nd pre-test: 20.5 - 20.1 g; main study 19.1. - 22.5 g
- Housing: group of 2 (pre-studies)/ 4 (main study) animals per cage in Makrolon Type II (pre-test)/ III (main study), with wire mesh top, granulated soft wood bedding
- Diet: 2018C Teklad Global 18% protein rodent diet (certified), ad libitum
- Water: tap water, ad libitum
- Acclimation period: at least 5 days prior start of dosing

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2
- Humidity (%): 45 - 65, except for several hours on four non consecutive days (28 - 65%)
- Photoperiod (hrs dark / hrs light): 12/12

Study design: in vivo (LLNA)

Vehicle:
acetone/olive oil (4:1 v/v)
Concentration:
5, 10 and 25%
No. of animals per dose:
4
Details on study design:
RANGE FINDING TESTS:The first pre-test was performed with 50 and 100% test item concentration. Animals treated with 50% test item concentration showed an erythema of the ear skin (Score 1) on day 1 to 4. Animals treated with 100% test item concentration showed an erythema of the ear skin (Score 1) between day 1 and 5. The ear thickness for animals treated with 50% test item concentration increased by 27.2% which is considered as an excessive ear irritation because the increase in ear weight is ≥ 25%. The second pre-test was performed with 10 and 25% test item concentration. Animals treated with 10% test item concentration showed an erythema of the ear skin (Score 1) on day 3. Animals treated with 25% test item concentration showed an erythema of the ear skin (Score 1) between day 2 and 3. Due to these results the test item concentration in the main study was assayed at 5, 10 and 25%, where the highest concentration tested was the highest concentration level that could be achieved whilst avoiding systemic toxicity and excessive local skin irritation.
MAIN STUDYANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: 3H-methyl thymidine incorporation determined by β-scintillation
- Criteria used to consider a positive response:
A) the exposure to at least one concentration of the test item resulted in an incorporation of 3HTdR at least 3-fold or greater than that recorded in control mice, as indicated by the Stimulation Index,
B) the data are compatible with a conventional dose response, although allowance must be made (especially at high topical concentrations) for either local toxicity or immunological suppression.
TREATMENT PREPARATION AND ADMINISTRATION: 25 µL of the test item was spread over the entire dorsal surface of each ear of each mouse once daily for three consecutive days. Local irritation reactions were assessed. On day 6, 250 µL of phosphate-buffered saline containing 20.4 µCi of 3H-methyl thymidine were injected into each test and control mouse via the tail vein. Approximately 5 h later the draining lymph nodes were excised and pooled for each treatment group. A single cell suspension of lymph node cells of pooled lymph nodes was prepared by gentle mechanical disaggregation through stainless steel gauze (200 µm mesh size). Macromolecules were precipitated with 5% trichloroacetic acid at 4 °C for at least 18 h.
Positive control substance(s):
hexyl cinnamic aldehyde (CAS No 101-86-0)

Results and discussion

Positive control results:
The positive control substance α-hexyl cinnamic aldehyde with a concentration of 25% in acetone/olive oil (4 + 1; v/v) induced a positive reaction with a stimulation index of 6.79.

In vivo (LLNA)

Resultsopen allclose all
Key result
Parameter:
SI
Value:
0.49
Test group / Remarks:
5% test substance in acetone/olive oil (4 + 1; v/v)
Key result
Parameter:
SI
Value:
0.76
Test group / Remarks:
10% test substance in acetone/olive oil (4 + 1; v/v)
Key result
Parameter:
SI
Value:
1.03
Test group / Remarks:
25%test substance in acetone/olive oil (4 + 1; v/v)
Key result
Parameter:
other: disintegrations per minute (DPM)
Value:
1 027.5
Test group / Remarks:
Negative control group
Key result
Parameter:
other: disintegrations per minute (DPM)
Value:
504.1
Test group / Remarks:
5% test substance in acetone/olive oil (4 + 1; v/v)
Key result
Parameter:
other: disintegrations per minute (DPM)
Value:
775.9
Test group / Remarks:
10% test substance in acetone/olive oil (4 + 1; v/v)
Key result
Parameter:
other: disintegrations per minute (DPM)
Value:
1 063
Test group / Remarks:
25% test substance in acetone/olive oil (4 + 1; v/v)
Key result
Parameter:
SI
Value:
6.79
Test group / Remarks:
Positive control 25% α-hexylcinnamaldehyde in acetone/olive oil (4+1; v/v)

Any other information on results incl. tables

No signs of systemic toxicity were observed during the study period. Animals treated with 25% test item concentration showed an erythema of the ear skin with a score of 1 on day 3 and 4, whereas animals treated with 5 and 10% test item concentration did not show any signs of local skin irritation.

The body weights of the animals were recorded prior the first application and before treatment with 3H-methyl-thymidine. The weights were within the range commonly recorded for animals of this strain and age.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
In the key local lymph node assay, conducted according to OECD Test Guideline 429 and in compliance with GLP, the test substance, Cyrene™, was concluded to be not sensitising to skin based on Stimulation Index (SI) values of <3 when tested at 5, 10 or 25% concentration.